In the pharmaceutical sector, fewer incidents of regulatory breaches and attractive valuations drove fund managers to add stocks such as Alkem Laboratories, Ajanta Pharma, and Dr Reddy’s Laboratories.
In the pharmaceutical sector, fewer incidents of regulatory breaches and attractive valuations drove fund managers to add stocks such as Alkem Laboratories, Ajanta Pharma, and Dr Reddy’s Laboratories.
Money managers at leading fund houses took fresh exposures to real estate and pharmaceutical stocks in April, a month when the Sensex and Nifty rose 3.59% and 4.06%, respectively. Peaking out of interest rates and recent stock price underperformance are the major reasons fund managers bought into prominent realty companies such as DLF, Prestige Estates, and Godrej Properties.
In the pharmaceutical sector, fewer incidents of regulatory breaches and attractive valuations drove fund managers to add stocks such as Alkem Laboratories, Ajanta Pharma, and Dr Reddy’s Laboratories. Mutual funds continued to shuffl e their holdings in IT and banking sectors in April, while at least two large AMCs — ICICI Prudential and Nippon — trimmed their stakes in ITC — one of the top performers in recent months. ET takes a look at some of the top holdings changes of leading mutual funds.
Get Unlimited Access to The Economic Times
